Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.

Measuring breast, colorectal, and prostate cancer screening with medicare claims data.

Freeman JL, Klabunde CN, Schussler N, Warren JL, Virnig BA, Cooper GS.

Med Care. 2002 Aug;40(8 Suppl):IV-36-42.

PMID:
12187166
2.

Data sources for measuring colorectal endoscopy use among Medicare enrollees.

Schenck AP, Klabunde CN, Warren JL, Peacock S, Davis WW, Hawley ST, Pignone M, Ransohoff DF.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2118-27.

3.

Trends in colorectal cancer test use in the medicare population, 1998-2005.

Schenck AP, Peacock SC, Klabunde CN, Lapin P, Coan JF, Brown ML.

Am J Prev Med. 2009 Jul;37(1):1-7. doi: 10.1016/j.amepre.2009.03.009. Epub 2009 May 7.

PMID:
19423273
4.

Effect of Medicare coverage on use of invasive colorectal cancer screening tests.

Ko CW, Kreuter W, Baldwin LM.

Arch Intern Med. 2002 Dec 9-23;162(22):2581-6.

PMID:
12456230
5.

Trends in colorectal cancer testing among Medicare subpopulations.

Fenton JJ, Cai Y, Green P, Beckett LA, Franks P, Baldwin LM.

Am J Prev Med. 2008 Sep;35(3):194-202. doi: 10.1016/j.amepre.2008.05.029. Epub 2008 Jul 10.

PMID:
18619761
6.

The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.

El-Serag HB, Petersen L, Hampel H, Richardson P, Cooper G.

Arch Intern Med. 2006 Nov 13;166(20):2202-8.

PMID:
17101937
7.

Utility of the SEER-Medicare data to identify chemotherapy use.

Warren JL, Harlan LC, Fahey A, Virnig BA, Freeman JL, Klabunde CN, Cooper GS, Knopf KB.

Med Care. 2002 Aug;40(8 Suppl):IV-55-61.

PMID:
12187169
8.

Cancer screening before and after switching to a high-deductible health plan.

Wharam JF, Galbraith AA, Kleinman KP, Soumerai SB, Ross-Degnan D, Landon BE.

Ann Intern Med. 2008 May 6;148(9):647-55.

PMID:
18458277
9.

Racial disparities and trends in use of colorectal procedures among Tennessee elderly (1996-2000).

Zhao BB, Kilbourne B, Stain SC, Van Cain A, Briggs NC, Husaini BA, Levine R.

Ethn Dis. 2006 Spring;16(2):412-20.

PMID:
17682243
10.

Increase in screening for colorectal cancer in older Americans: results from a national survey.

Chen X, White MC, Peipins LA, Seeff LC.

J Am Geriatr Soc. 2008 Aug;56(8):1511-6. doi: 10.1111/j.1532-5415.2008.01796.x. Epub 2008 Jul 24.

PMID:
18662217
11.

Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector?

Keating NL, Landrum MB, Meara E, Ganz PA, Guadagnoli E.

J Natl Cancer Inst. 2005 Feb 16;97(4):257-64.

PMID:
15713960
12.

Health plan policies and programs for colorectal cancer screening: a national profile.

Klabunde CN, Riley GF, Mandelson MT, Frame PS, Brown ML.

Am J Manag Care. 2004 Apr;10(4):273-9.

13.

Use of SEER-Medicare data for measuring cancer surgery.

Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL.

Med Care. 2002 Aug;40(8 Suppl):IV-43-8.

PMID:
12187167
14.

A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.

Klabunde CN, Legler JM, Warren JL, Baldwin LM, Schrag D.

Ann Epidemiol. 2007 Aug;17(8):584-90. Epub 2007 May 25.

PMID:
17531502
15.

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.

Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK.

J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. Review. Erratum in: J Natl Cancer Inst. 2003 Nov 5;95(21):1641.

PMID:
12953083
16.

Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for service.

Schenck AP, Klabunde CN, Warren JL, Peacock S, Davis WW, Hawley ST, Pignone M, Ransohoff DF.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):799-804. doi: 10.1158/1055-9965.EPI-07-2620. Epub 2008 Apr 1.

17.

Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?

Schneider EC, Rosenthal M, Gatsonis CG, Zheng J, Epstein AM.

Med Care. 2008 Sep;46(9 Suppl 1):S84-90. doi: 10.1097/MLR.0b013e31817fdf80.

PMID:
18725838
18.

Measuring the quality of colorectal cancer screening: the importance of follow-up.

Etzioni DA, Yano EM, Rubenstein LV, Lee ML, Ko CY, Brook RH, Parkerton PH, Asch SM.

Dis Colon Rectum. 2006 Jul;49(7):1002-10.

PMID:
16673056
19.

Cancer screening estimates for U.S. metropolitan areas.

Nelson DE, Bolen J, Marcus S, Wells HE, Meissner H.

Am J Prev Med. 2003 May;24(4):301-9.

PMID:
12726867
20.

Receipt of colorectal testing prior to colorectal carcinoma diagnosis.

Cooper GS, Payes JD.

Cancer. 2005 Feb 15;103(4):696-701.

Supplemental Content

Support Center